11.4.2022 | Savon Sanomat

Marginum wins start-up competition at Tahko Ski Lift Pitch 2022

Marginum Ltd from Kuopio was the winner of the Tahko Ski Lift Pitch start-up competition which was held for the fifth time.
 
The company’s technology increases the efficiency of cancer surgery with fluorescence-based monitoring techniques. The research-driven invention emerged from the need to develop more effective tissue recognition techniques for surgical treatment of tumours.
 
Twenty startups advanced to the semi-finals held in Nilsiä’s Tahko. The winner redeemed 10 000 € in prize money in addition to being featured on the Nasdaq tower in Times Square New York City.
 
The event, which has been held at Tahko since 2017, brings together investors, experts, collaborators and start-ups of different stages. 
 
Original full article in Finnish can be read at Savon Sanomat.

LATEST NEWS & PRESS

14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.

27.4.2022 | Finnish Medical Journal

Smart tissue monitor detects cancer tissues from surgical waste

Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.

25.4.2022 | Mediuutiset

New tool for brain surgery in development for neurosurgeons

Contemporary techniques in glioma surgery are limited by their complexity, subjectivity and randomness, resulting in reoperations and suboptimal care.

11.4.2022 | Savon Sanomat

Marginum wins start-up competition at Tahko Ski Lift Pitch 2022

Marginum was selected as the winner of Tahko Ski Lift Pitch and awarded with the chance to be featured on the Nasdaq billboard in New York's Times Square.

7.2.2022 | Finnish Venture Capital Association

Smart tissue monitor developing Marginum Ltd raises first venture capital funding from Nostetta Ventures

Finnish start-up Marginum raises first venture capital funding from Nostetta Ventures for the commercialisation of smart tissue monitor.

5.2.2022 | Savon Sanomat

CEO Samu Lehtonen in Savon Sanomat

CEO Lehtonen shared his thoughts on the development of Marginum’s technology and on how the innovation was borne from multidisciplinary research.